Compare · CHEK vs GEHC
CHEK vs GEHC
Side-by-side comparison of Check-Cap Ltd. (CHEK) and GE HealthCare Technologies Inc. (GEHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHEK and GEHC operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $30.93B, about 1454.2x CHEK ($21.3M).
- Over the past year, CHEK is down 22.6% and GEHC is down 5.0% - GEHC leads by 17.6 points.
- GEHC has hit the wire 9 times in the past 4 weeks while CHEK has been quiet.
- GEHC has more recent analyst coverage (25 ratings vs 1 for CHEK).
- Company
- Check-Cap Ltd.
- GE HealthCare Technologies Inc.
- Price
- $1.61+0.63%
- $69.73-0.91%
- Market cap
- $21.3M
- $30.93B
- 1M return
- +6.62%
- +8.18%
- 1Y return
- -22.60%
- -4.98%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- News (4w)
- 0
- 9
- Recent ratings
- 1
- 25
Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.
Latest CHEK
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- MBody AI and Check-Cap Enter into Definitive Merger Agreement
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 20-F filed by Check-Cap Ltd.
- Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime
Latest GEHC
- Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow
- GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68
- Barclays initiated coverage on GE HealthCare with a new price target
- GE HealthCare to announce third quarter 2026 results on October 28, 2026
- GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.
- GE HealthCare announces cash dividend increase for third quarter of 2026
- GE HealthCare Technologies Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
- Needham initiated coverage on GE HealthCare with a new price target
- Chief Financial Officer Grogan William K was granted 75,096 shares (SEC Form 4)